山东药玻控股股东拟变更：国药国际增资鲁中投资，将间接控股

财中社2025-06-22

6月22日，山东药玻（600529）发布公告，控股股东重组事宜取得进展。2025年6月20日，国药国际及其全资子公司国药国际香港与鲁中控股及其他投资方签署了增资协议，国药国际和国药国际香港将向鲁中投资增资24.49亿元，获得其51%股权。通过这一增资，国药国际将通过鲁中投资间接控股山东药玻1.29亿股股份，占总股本的19.496418%。此次重组将使公司间接控股股东由鲁中控股变更为国药国际，实际...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2545310874?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-06-22 18:12","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2545310874","market":"sh","top_or_hot":-1,"title":"山东药玻控股股东拟变更：国药国际增资鲁中投资，将间接控股","media":"财中社","content":"<div>\n<p>6月22日，山东药玻（600529）发布公告，控股股东重组事宜取得进展。2025年6月20日，国药国际及其全资子公司国药国际香港与鲁中控股及其他投资方签署了增资协议，国药国际和国药国际香港将向鲁中投资增资24.49亿元，获得其51%股权。通过这一增资，国药国际将通过鲁中投资间接控股山东药玻1.29亿股股份，占总股本的19.496418%。此次重组将使公司间接控股股东由鲁中控股变更为国药国际，实际...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506221812279526a0c2&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>山东药玻控股股东拟变更：国药国际增资鲁中投资，将间接控股</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n山东药玻控股股东拟变更：国药国际增资鲁中投资，将间接控股\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-06-22 18:12 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506221812279526a0c2&s=b><strong>财中社</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>6月22日，山东药玻（600529）发布公告，控股股东重组事宜取得进展。2025年6月20日，国药国际及其全资子公司国药国际香港与鲁中控股及其他投资方签署了增资协议，国药国际和国药国际香港将向鲁中投资增资24.49亿元，获得其51%股权。通过这一增资，国药国际将通过鲁中投资间接控股山东药玻1.29亿股股份，占总股本的19.496418%。此次重组将使公司间接控股股东由鲁中控股变更为国药国际，实际...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506221812279526a0c2&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0235","symbol_name":"非金矿物","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506221812279526a0c2&s=b","article_id":"2545310874","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506221812279526a0c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2545310874","pubTimestamp":1750587121,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"2025年6月20日，国药国际及其全资子公司国药国际香港与鲁中控股及其他投资方签署了增资协议，国药国际和国药国际香港将向鲁中投资增资24.49亿元，获得其51%股权。通过这一增资，国药国际将通过鲁中投资间接控股山东药玻1.29亿股股份，占总股本的19.496418%。此次重组将使公司间接控股股东由鲁中控股变更为国药国际，实际控制人也将由沂源县财政局变更为国药集团。2025年一季度，山东药玻实现收入12.42亿元，归母净利润2.24亿元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"600529":"山东药玻","BK0235":"非金矿物","BK0186":"小盘成长"},"translate_title":"The controlling shareholder of Shandong Pharmaceutical Glass plans to change: Sinopharm International increases its capital in Luzhong Investment and will indirectly control","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600529":1},"content_text":"6月22日，山东药玻（600529）发布公告，控股股东重组事宜取得进展。2025年6月20日，国药国际及其全资子公司国药国际香港与鲁中控股及其他投资方签署了增资协议，国药国际和国药国际香港将向鲁中投资增资24.49亿元，获得其51%股权。通过这一增资，国药国际将通过鲁中投资间接控股山东药玻1.29亿股股份，占总股本的19.496418%。此次重组将使公司间接控股股东由鲁中控股变更为国药国际，实际控制人也将由沂源县财政局变更为国药集团。公告中指出，本次权益变动不会对公司的主营业务、财务状况和独立性造成重大影响，但仍需经过相关部门的审批，最终完成时间存在不确定性。2025年一季度，山东药玻实现收入12.42亿元，归母净利润2.24亿元。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2545310874","isCrawlerRequest":true}